DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 05 · Volume 22 · 1969 DOI: 10.1055/s-008-39965

Originalarbeiten — Original Articles — Travaux Originaux

  • 211
    Isacson, S; Marie Nilsson, Inga:

    The Kidneys and the Fibrinolytic Activity in the Blood

    • Originalarbeiten-Original Articles-Travaux Originaux

  • 216
    Losowsky, M. S; Walls, W. D:

    Abnormal Fibrin Stabilization in Renal Failure

  • 223
    Gallimore, M. J; Shaw, J. T. B:

    The Influence of Various Plasma Components on the Lysis of Dilute Human Blood Clots

  • 234
    Marder, V. J; James, H. L; Sherry, S:

    The Purification of Fibrinogen Degradation Products by Pevikon Block Electrophoresis

  • 240
    Stuckey, R. J; Wolf, P:

    Diffusion Characteristics of Human Plasminogen(as Shown by Two Agar Diffusion Techniques)

  • 251
    Aoki, N; von Kaulla, K. N:

    Inactivation of Human Serum Plasminogen Antiactivator by Synthetic Fibrinolysis Inducers

  • 263
    Baumgarten, W; Priester, L. I; Stiller, D. W; Duncan, A. E. W; Ciminera, J. L; Loeffler, L. J:

    4-Aninomethylbicyclo[2.2.2]-Octane-1-Carboxylic Acid a New Potent Antifibrinolytic Agent

  • 273
    von Felten, A; Straub, P. W:

    Coagulation Studies of Cord Blood, with Special Reference to “Fetal Fibrinogen”

  • 281
    Murphy, E. A; Francis, M. E:

    The Estimation of Blood Platelet Survival

  • 296
    Heřmanský, F; Caen, J; Matoušová, O:

    Some New Observations on Glycogenolysis in Blood Platelets Studied by Cytochemical Scoring Method

  • 304
    Salzman, E. W; Ashford, T. P; Chambers, D. A; Neri, Lena L.:

    Platelet Incorporation of Labelled Adenosine and Adenosine Diphosphate

  • 316
    Saito, H; Shioya, M; Koie, K; Kamiya, T; Katsumi, O:

    Congenital Combined Deficiency of Factor V and Factor VIII

  • 326
    Schimpf, KL; Barth, P; Bartman, J; Freienberg, J; Hansen, B; Meier, J:

    The Coagulation System during the Passage of Blood through the Body

  • 336
    Mueller-Eckhardt, Ch; Heene, D; Müller-Berghaus, G; Lasch, H. G:

    Hämolytische Transfusionszwischenfälle mit »Verbrauchskoagulopathie« durch seltene Blutgruppenantikörper [Anti-Duffy (a)]

  • 344
    Engelberg, H:

    Studies with the Chandler Rotating Loop

  • 351
    Frost, H:

    Zur Pathogenese obliterierender Arterienprozesse bei Hypercholesterinämie

  • 360
    Saldeen, T:

    The Disappearance of Fibrin from the Pulmonary Vessels in Experimental Fat Embolism

  • 372
    Bańkowski, E; Worowski, K:

    The Effect of Chronic Administration of Lathyrogen (Beta-Aminopropionitrile) on Blood Clotting and Fibrinolytic System in Rabbits

  • 377
    Andrassy, K; Egbring, R; Egli, H:

    Über die fibrinolytische Aktivität von Rinderprothrombinpräparaten nach Seegers

    • Übersichten- Reviews- Revues Générales

  • 391
    Roskam, J:

    Bleeding Time and Surgical Blood Losses in Nonhemorrhagic People

    • Vorläufige Mitteilungen - Preliminary Reports - Communication préliminaires

  • 396
    Reuter, H; Linker, H; Gross, R:

    Ein möglicher Mechanismus der Desaggregation ADP-induzierter Aggregate durch Imipramin und strukturverwandte Verbindungen

  • 408
    Farbiszewski, R; Lipiński, B; Lebenstein, W:

    Plasma Antiheparin Activity, Soluble Fibrin Monomer Complexes and Fibrinolysis in Plasma of Patients after Surgery

    • Vorläufige Mitteilungen — Preliminary Reports — Communications Préliminaires

  • 398
    Tyler, H. M:

    Fibrin Crosslinking Demonstrated by Thrombelastography

  • 401
    Lipiński, B:

    Demonstration of Antiparacoagulating Activity of Acid Mucopolysaccharides and Extracts of the Aortic Wall

  • 403
    Moriau, M:

    Have the Platelet Antiheparin and Antiplasmin Activities the Same Support?